The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
Credit Crisis: “Jaws” attacks again.
This morning, investors are digesting a staggering loss and break up of Citigroup (NYSE: C) and another bailout for Bank of America (NYSE: BAC). The credit crisis seems to be playing out like the shark from Jaws.
It just keeps coming. You never know when it’s going to strike. And unlike the theatrical release, we don’t have John William’s soundtrack to warn us.
Citigroup announced a massive $8.3 billion loss and plans to split into two. It’s hoping a “two-face” strategy will work. They plan to make the profitable division into one company, and move all it’s bad assets into another. It’s the perfect solution for value and growth investors. Unfortunately, we think they will be hard pressed to figure out which company is which.
Bank of America is getting another $20 billion and guarantees for more than $100 billion of toxic Merrill Lynch assets. This now makes them the largest recipient of bailout funds.
Just like in Jaws, every time the authorities calm the public down, that’s when the shark strikes. Investors had just started thinking things were getting better. But here’s the interesting thing. In early November, Investment U researchers reasoned that any bank receiving federal bailout funds wouldn’t be allowed to fail.
With Bank of America’s announcement, we are sadly witnessing that come true. To read more, see the “9 Banks the U.S. Guarantees.”
Companies mentioned in this article: C and BAC.
- Citigroup Gets Treasury “Seal of Approval”
- Banks Pushing the Limit?
- Citigroup’s Multiple Personalities
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed